An estimated 1.5 million Americans have lupus and live with the chronic disease that has no known cure, affects many parts of the body and can be life-threatening. Systemic lupus
There are more than 58.5 million adults living with arthritis everyday in the U.S. and that number continues to grow, making the research and scientists ANRF funds more important than
2021-22 Grant Recipient Recent Research Sarah Baxter, M.D., Ph.D., University of Washington International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis Molecular diagnosis
On March 18th & 19th, the Newkirk Alumni Center at the University of California, Irvine campus provided the space for current ANRF grant funded scholars, the Scientific Advisory Board (SAB),
Make a one-time or recurring donation and know you are making a difference by funding cutting-edge arthritis & related autoimmune disease research.
An estimated 1.5 million Americans have lupus and live with the chronic disease that has no known cure, affects many parts of the body and can be life-threatening. Systemic lupus
There are more than 58.5 million adults living with arthritis everyday in the U.S. and that number continues to grow, making the research and scientists ANRF funds more important than
2021-22 Grant Recipient Recent Research Sarah Baxter, M.D., Ph.D., University of Washington International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis Molecular diagnosis
Stay up -to-date with the latest arthritis news, stories and info.
Charitable estate planning is financially beneficial for families and individuals of various ages and income levels, and ensures a legacy of commitment to making a difference through funding research, while supporting ANRF’s mission.
19200 Von Karman Ave.
Suite 350
Irvine, CA 92612
800.588.2873
Tax ID #: 95-6043953
Make a one-time or recurring donation and know that you are making a difference by funding cutting-edge arthritis research.
